Captopril and Integrilin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Captopril (captopril) and Integrilin (eptifibatide). Common drug interactions include cerebral arteriosclerosis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Captopril and Integrilin. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.

What is Integrilin?

Integrilin has active ingredients of eptifibatide. eHealthMe is studying from 3,037 Integrilin users. Check the latest studies of Integrilin.



On Jul, 13, 2026

36 people who take Captopril and Integrilin together, and have interactions are studied.

Captopril and Integrilin drug interactions.

What are the common drug interactions of Captopril and Integrilin, by gender? *:

female:

  1. Cerebral arteriosclerosis (thickening and hardening of the walls of the arteries in the brain)
  2. Mitral valve incompetence (inefficient heart valve)
  3. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  4. Pleural adhesion
  5. Renal cyst (kidney cyst)
  6. Spinal epidural haemorrhage (bleeding into the epidural space in the spine)
  7. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Haematoma (collection of blood outside the blood vessels)
  10. Hepatic steatosis (fatty liver disease)

male:

  1. Anxiety
  2. Emotional distress
  3. Stress
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Hypotension (abnormally low blood pressure)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Lethargy (tiredness)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Captopril and Integrilin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Injury
  3. Pain
  4. Psychiatric symptom
  5. Renal failure (kidney dysfunction)

40-49:

  1. Cardiac procedure complication
  2. Non-cardiac chest pain
  3. Pleuritic pain
  4. Ventricular fibrillation (abnormally irregular heart rhythm)

50-59:

  1. Anxiety
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Death
  4. Depression
  5. Emotional distress
  6. Fear
  7. Hypotension (abnormally low blood pressure)
  8. Lethargy (tiredness)
  9. Multi-organ failure (multisystem organ failure)
  10. Pain

60+:

  1. Pneumonia
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Aortic valve incompetence
  4. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  5. Cerebral arteriosclerosis (thickening and hardening of the walls of the arteries in the brain)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  8. Pleural adhesion
  9. Renal cyst (kidney cyst)
  10. Subdural haemorrhage (bleeding between the skull and the surface of the brain)

What are the existing conditions these people have? *

  1. Heart Attack: 17 people, 47.22%
  2. Pain: 5 people, 13.89%
  3. Chest Pain: 5 people, 13.89%
  4. Stress And Anxiety: 2 people, 5.56%
  5. Headache (pain in head): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and Integrilin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Captopril and Integrilin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Integrilin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Captopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Integrilin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on captopril and eptifibatide (the active ingredients of Captopril and Integrilin, respectively), and Captopril and Integrilin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: